In this review, we summarise current knowledge regarding the secretion and insulinotropic action of GIP and GLP-1, their contribution to the incretin effect, and their effects on glucagon secretion, gastric emptying, appetite and energy intake in people with type 2 diabetes and healthy individuals. Here, GIP is linked to type 2 diabetes mellitus.